<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="114403">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02027467</url>
  </required_header>
  <id_info>
    <org_study_id>SV/121108/SA/HSC</org_study_id>
    <nct_id>NCT02027467</nct_id>
  </id_info>
  <brief_title>Study to Assess the Effect of StemAlive® Supplement on the Levels of Stem Cells in Human Volunteers</brief_title>
  <acronym>Hematoalive</acronym>
  <official_title>Assessment of the Effect of StemAlive® Herbal Supplement on the Levels of Circulating Hematopoietic Stem Cells in Human Volunteers</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Vedic Lifesciences Pvt. Ltd.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Stem Vida International</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Vedic Lifesciences Pvt. Ltd.</source>
  <oversight_info>
    <authority>India: Institutional Review Board</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Combination of various herbs is known to promote mobilization of hematopoietic stem cells.
      Hence the current study has been intended to study the effect of Stem Alive® on mobilization
      of stem cells.  Stem Alive® include ingredients like green tea, ashwagandha, etc which are
      known to be used as traditional medicine.  They are also tested qualitatively in academic
      and nutritional science research centers throughout the world and which substantially
      according to those studies stimulate the augmented availability of circulating hematopoietic
      cells. This study is projected to investigate the mobilization of stem cells on healthy
      human volunteers.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>February 2014</start_date>
  <completion_date type="Actual">April 2014</completion_date>
  <primary_completion_date type="Actual">April 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator)</study_design>
  <primary_outcome>
    <measure>CD34+</measure>
    <time_frame>Day 0, Day 1, Day 2, Day 7, Day 12 and Day 14</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <primary_outcome>
    <measure>CD45+</measure>
    <time_frame>Day 0, Day 1, Day 2, Day 7, Day 12 and Day 14</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <primary_outcome>
    <measure>CD133+</measure>
    <time_frame>Day 0, Day 1, Day 2, Day 7, Day 12 and Day 14</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">23</enrollment>
  <condition>Healthy</condition>
  <arm_group>
    <arm_group_label>StemAlive®</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Stem Alive® includes ingredients like green tea, ashwagandha. Dose: 3 capsules twice daily to be taken orally for 14 days.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Matching placebo capsules (for StemAlive®) containing polyethylene glycol, rice powder and magnesium stearate. Dose: 3 capsules twice daily to be taken orally for 14 days.</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>StemAlive®</intervention_name>
    <arm_group_label>StemAlive®</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Placebo (For StemAlive®)</intervention_name>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Healthy Male and Female Volunteers

          -  Willing to sign Informed Consent Form

        Exclusion Criteria:

          -  Anemia

          -  SGOT and Serum Creatinine values twice the upper limit of normal

          -  Volunteers who smoke / consume alcohol / take recreational drugs

          -  Fever or Flu in the last one week of screening

          -  History of Gastric or Duodenal Ulcer

          -  Volunteers on vitamins, nutritional or herbal products since last one month

          -  Pregnant, Breast feeding and Lactating women

          -  Volunteers taking antibiotic, NSAIDS, anti-inflammatory within last 7 days

          -  Allergic to ingredients of test product

          -  Any co morbid or systemic condition or immunocompromised state making volunteer unfit
             for participation.

          -  Volunteers deemed unfit for the study by the Investigator
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sandip Patil, MD</last_name>
    <role>Principal Investigator</role>
  </overall_official>
  <location>
    <facility>
      <name>Dhanwantari Clinic</name>
      <address>
        <city>Mumbai</city>
        <state>Maharashtra</state>
        <zip>400072</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>India</country>
  </location_countries>
  <verification_date>May 2014</verification_date>
  <lastchanged_date>May 3, 2014</lastchanged_date>
  <firstreceived_date>November 18, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Hematopoietic stem cells</keyword>
  <keyword>Herbal</keyword>
  <keyword>Dietary</keyword>
  <keyword>CD cells</keyword>
  <keyword>Basic research</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
